Skip to content

MDL studies: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MDL studies

BE 1014.612.476
NACE 86.910, Medical imaging and medical laboratories
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€250,179
2024 · €162,100+€88,079
Equity
€417,519
2024 · €167,340+€250,179
Cash
€324,352
2024 · €154,691+€169,661
Balance sheet total
€555,594
2024 · €356,114+€199,481

Largest movements

2024 to 2025
Assets
  • Cash +€169,661

    up €169,661 (+109.7%), from €154,691 to €324,352

    mainly Net result for the year (+€250,179) and Tax, wage and social debts (+€19,619)

  • Receivables within one year +€29,820

    up €29,820 (+14.8%), from €201,423 to €231,243

    of which Trade receivables: +€27,651

Equity and liabilities
  • Reserves +€250,179

    up €250,179 (+154.3%), from €162,100 to €412,279

  • Trade debts -€70,317

    down €70,317 (-55.0%), from €127,756 to €57,439

  • Tax, wage and social debts +€19,619

    up €19,619 (+32.2%), from €61,018 to €80,636

Income statement
  • Gross operating margin +€137,978

    up €137,978 (+65.7%), from €210,040 to €348,019

  • Taxes +€31,175

    up €31,175 (+65.8%), from €47,400 to €78,575

  • Staff costs +€18,663

    new in 2025: €18,663

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €162,100
Gross operating margin +€137,978
Staff costs -€18,663
Other operating charges -€2
Financial charges -€60
Taxes -€31,175
Result 2025 €250,179

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€169,661
Investment €0
Financing €0
Cash 2024 €154,691
Net result for the year +€250,179
Receivables within one year -€29,820
Trade debts -€70,317
Tax, wage and social debts +€19,619
Cash 2025 €324,352
Every line side by side 27 lines
Line Code 2024 2025 Change %
Total assets 20/58 €356,114 €555,594 +€199,481 +56.0%
Current assets 29/58 €356,114 €555,594 +€199,481 +56.0%
Amounts receivable within one year 40/41 €201,423 €231,243 +€29,820 +14.8%
Trade receivables 40 €6,049 €33,700 +€27,651 +457.2%
Other amounts receivable 41 €195,375 €197,543 +€2,168 +1.1%
Cash at bank and in hand 54/58 €154,691 €324,352 +€169,661 +109.7%
Total equity and liabilities 10/49 €356,114 €555,594 +€199,481 +56.0%
Equity 10/15 €167,340 €417,519 +€250,179 +149.5%
Contributions 10/11 €5,240 €5,240 = 0.0%
Reserves 13 €162,100 €412,279 +€250,179 +154.3%
Distributable reserves 133 €162,100 €412,279 +€250,179 +154.3%
Amounts payable 17/49 €188,773 €138,075 -€50,698 -26.9%
Amounts payable within one year 42/48 €188,773 €138,075 -€50,698 -26.9%
Trade debts 44 €127,756 €57,439 -€70,317 -55.0%
Suppliers 440/4 €127,756 €57,439 -€70,317 -55.0%
Taxes, remuneration and social security 45 €61,018 €80,636 +€19,619 +32.2%
Taxes 450/3 €61,018 €80,636 +€19,619 +32.2%
Remuneration, social security and pensions 62 - €18,663 +€18,663
Other operating charges 640/8 €537 €539 +€2 +0.3%
Gross operating margin 9900 €210,040 €348,019 +€137,978 +65.7%
Operating profit (loss) 9901 €209,503 €328,817 +€119,314 +57.0%
Financial charges 65/66B €3 €63 +€60 +2402.8%
Recurring financial charges 65 €3 €63 +€60 +2402.8%
Profit (loss) for the period before taxes 9903 €209,500 €328,754 +€119,254 +56.9%
Income taxes 67/77 €47,400 €78,575 +€31,175 +65.8%
Profit (loss) for the period 9904 €162,100 €250,179 +€88,079 +54.3%
Profit (loss) for the period to be appropriated 9905 €162,100 €250,179 +€88,079 +54.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 11 October 2026 via checked.be.